UB Paderborn / Katalog / Suche / in CDI

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

Frontiers in oncology, 2023-08, Vol.13, p.1220305-1220305

2023

Link zum Volltext

Verfügbarkeit prüfen

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

Frontiers in public health, 2022-11, Vol.10, p.978783

2022

Link zum Volltext

Verfügbarkeit prüfen

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.475-484

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative study of preparation of hazardous drugs with different closed-system drug transfer devices by means of simulation with fluorescein

Farmacia hospitalaria, 2016-11, Vol.40 (6), p.496-503

2016

Link zum Volltext

Verfügbarkeit prüfen

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

Supportive care in cancer, 2021-06, Vol.29 (6), p.3121-3127

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain

ClinicoEconomics and outcomes research, 2018-01, Vol.10, p.773-790

2018

Link zum Volltext

Verfügbarkeit prüfen

Error Detection and Cost Savings With an Image-Based Workflow Management System Connected to a Computerized Prescription Order Entry Program for Antineoplastic Compounding

Journal of patient safety, 2021-12, Vol.17 (8), p.e1589

2021

Link zum Volltext

Verfügbarkeit prüfen

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Frontiers in oncology, 2022-06, Vol.12, p.889575-889575

2022

Link zum Volltext

Verfügbarkeit prüfen

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer

Oncotarget, 2015-03, Vol.6 (8), p.6422-6430

2015

Link zum Volltext

Verfügbarkeit prüfen

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study

The European journal of health economics, 2019-02, Vol.20 (1), p.135-147

2019

Link zum Volltext

Verfügbarkeit prüfen

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2021-03, Vol.45 (2), p.96

2021

Link zum Volltext

Verfügbarkeit prüfen

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

Cancer chemotherapy and pharmacology, 2013-06, Vol.71 (6), p.1463-1472

2013

Link zum Volltext

Verfügbarkeit prüfen

Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

Health informatics journal, 2020-09, Vol.26 (3), p.1995-2010

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

International journal of hematology, 2022-01, Vol.115 (1), p.61-68

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Cancer management and research, 2018-01, Vol.10, p.4517-4522

2018

Link zum Volltext

Verfügbarkeit prüfen

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Cancers, 2022-08, Vol.14 (16), p.3968

2022

Link zum Volltext

Verfügbarkeit prüfen

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Scientific reports, 2021-03, Vol.11 (1), p.7064-7064, Article 7064

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive biomarkers of response to immune checkpoint inhibitors

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2020-07, Vol.44 (4), p.141

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

European journal of hospital pharmacy. Science and practice, 2020-09, Vol.27 (5), p.299-301

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group

Cancers, 2021-09, Vol.13 (19), p.4762

2021

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer

Cancer chemotherapy and pharmacology, 2013-08, Vol.72 (2), p.491-491

2013

Link zum Volltext

Verfügbarkeit prüfen

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2018-11, Vol.42 (6), p.234

2018

Link zum Volltext

Verfügbarkeit prüfen

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

Journal of medical Internet research, 2018-10, Vol.20 (10), p.e11006-e11006

2018

Link zum Volltext

Verfügbarkeit prüfen

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (7), p.2855-2882

2023

Link zum Volltext

Verfügbarkeit prüfen

Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

Expert opinion on drug safety, 2022-01, Vol.21 (1), p.107-119

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Comparative study of preparation of hazardous drugs with different closed-system drug transfer devices by means of simulation with fluorescein

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain

Error Detection and Cost Savings With an Image-Based Workflow Management System Connected to a Computerized Prescription Order Entry Program for Antineoplastic Compounding

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Predictive biomarkers of response to immune checkpoint inhibitors

Evaluation of the use, effectiveness and safety of tyrosine kinase inhibitors in chronic myelogenous leukaemia in a general university hospital

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group

Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

Suchergebnisse filtern